Antisense oligonucleotide delivery to cancer cell lines for the treatment of different cancer types
dc.authorid | Bayram, Cem -- 0000-0001-8717-4668; | |
dc.contributor.author | Kılıçay, Ebru | |
dc.contributor.author | Erdal, Ebru | |
dc.contributor.author | Hazer, Baki | |
dc.contributor.author | Türk, Mustafa | |
dc.contributor.author | Denkbaş, Emir Baki | |
dc.date.accessioned | 13.07.201910:50:10 | |
dc.date.accessioned | 2019-07-29T19:28:16Z | |
dc.date.available | 13.07.201910:50:10 | |
dc.date.available | 2019-07-29T19:28:16Z | |
dc.date.issued | 2016 | |
dc.department | Sabire Yazıcı Fen Edebiyat Fakültesi | |
dc.description.abstract | Amphiphilic poly(3-hydroxylalkanoate) (PHA) copolymers find interesting applications in drug delivery. The aim of this study was to prepare nucleic acid adsorbed on (PHB-b-PEG-NH2) nanoparticle platform for gene delivery. For this purpose, PHB-b-PEG-NH2 block copolymers were synthesized via transesterification reactions. The copolymers obtained were characterized by Proton Nuclear Magnetic Resonance (H-1-NMR), Fourier Transform Infrared Spectrometer (FTIR), Thermogravimetric Analysis (TGA) and Differential Scanning Calorimetry (DSC) techniques. The cytotoxic, apoptotic and necrotic effects of these nanoparticles in the MDA 231 human breast cancer cell, the A549 human lung cancer cell and the L929 fibroblast cell lines were also investigated. | |
dc.description.sponsorship | Bulent Ecevit University Research Fund [BEU-2012-M6-00-03] | |
dc.description.sponsorship | This work was financially supported by the Bulent Ecevit University Research Fund (Grant no. BEU-2012-M6-00-03). | |
dc.identifier.doi | 10.3109/21691401.2015.1115409 | |
dc.identifier.endpage | 1948 | en_US |
dc.identifier.issn | 2169-1401 | |
dc.identifier.issn | 2169-141X | |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 26613393 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 1938 | en_US |
dc.identifier.uri | https://doi.org/10.3109/21691401.2015.1115409 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12451/6014 | |
dc.identifier.volume | 44 | en_US |
dc.identifier.wos | WOS:000385745200019 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Taylor & Francis Ltd | |
dc.relation.ispartof | Artificial Cells Nanomedicine And Biotechnology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Antisense Oligonucleotide | |
dc.subject | Fibroblast Cells | |
dc.subject | Human Breast Cancer Cells | |
dc.subject | Human Lung Cancer Cells | |
dc.subject | PHB-PEG Bock Copolymer | |
dc.subject | PHB-PEG Nanoparticle | |
dc.title | Antisense oligonucleotide delivery to cancer cell lines for the treatment of different cancer types | |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- kilicay-ebru-2016.pdf
- Boyut:
- 2.98 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text